Bausch + Lomb Corporation (BLCO) announced CEO and director Brent Saunders will depart effective October 12, 2026, and board chairman Thomas J. Appio will become interim CEO on that date. Appio will continue as CEO of parent Bausch Health Companies Inc. Saunders’ departure was mutually agreed and was not due to a dispute or disagreement over the company’s operations, policies or practices.
Under the separation agreement, Saunders is to receive a $75.5 million aggregate lump-sum cash payment and attorneys’ fee reimbursement up to $50,000; payment is contingent on his executing and not revoking a waiver and general release. He remains eligible for group health plan participation for two years. All outstanding equity and equity-based awards were forfeited and cancelled upon entering the agreement, and he is not entitled to further departure-related compensation or severance. He will provide reasonable transition assistance for 90 days after the separation date, with reasonable out-of-pocket expenses reimbursed.
Bausch + Lomb expects to raise full-year 2026 guidance for adjusted EBITDA excluding Acquired IPR&D, a non-GAAP measure, based on preliminary third-quarter results. It will provide additional details when it reports third-quarter results on October 28; the preliminary results remain subject to quarter-end closing and review procedures.
Bausch & Lomb Corp (BLCO) is named as issuer in a Rule 144 notice reporting former director Karen Ling’s proposed sale of 4,500 common shares through broker Fidelity Brokerage Services LLC. The reported aggregate market value is $75,735, and the approximate sale date is September 28, 2026. The notice lists the shares as originating from restricted stock vesting: 2,642 shares on May 28, 2024, and 1,858 shares on May 20, 2025.
Trebbi Barbara reported acquisition or exercise transactions in this Form 4 filing.
Bausch & Lomb Corp director Barbara Trebbi received an equity compensation award on 2026-08-12. She was granted 11,776 restricted share units (RSUs) under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. The RSUs are scheduled to vest immediately before the conclusion of the next annual meeting of shareholders and will be settled in common shares, resulting in direct ownership of 11,776 common shares after the award.
Bausch & Lomb Corp filed an initial statement of beneficial ownership for Barbara Trebbi, identifying her as a director of the company. The filing does not list any holdings or report any transactions in Bausch & Lomb securities. A power of attorney is referenced as an exhibit.
Bausch & Lomb Corp director Laurence E. Paul reported an acquisition of 11,776 Common Shares on 2026-08-12 through an annual grant of restricted share units (RSUs) for non-employee directors under the 2022 Omnibus Incentive Plan. These RSUs are scheduled to vest immediately before the next annual meeting of shareholders and will be settled in common shares upon vesting. Following this grant, Paul directly holds 11,776 common shares.
Bausch & Lomb Corp director Paul Laurence E filed an initial statement of beneficial ownership of securities as a Form 3. The filing lists him as a director and references an attached Exhibit 24 Power of Attorney, and it does not report any specific holdings or transactions.
Chersi Robert J reported acquisition or exercise transactions in this Form 4 filing.
Bausch & Lomb Corp director Robert J. Chersi received an equity compensation award of 11,776 restricted share units (RSUs) of common shares under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan. The RSUs will vest immediately before the conclusion of the next annual meeting of shareholders and are then settled in common shares. After this grant, Chersi directly holds 11,776 common shares.
Bausch & Lomb Corp disclosed that Robert J. Chersi is a reporting person in his capacity as a director. This initial ownership report lists no equity transactions or holdings details and notes an attached Power of Attorney authorizing certain filing-related actions.
Bausch & Lomb Corp director Thomas Appio filed an initial statement of beneficial ownership. The filing reports that he directly holds 27,583 Common Shares, No Par Value of Bausch & Lomb Corp as of the reported date. No new acquisitions, sales, or derivative positions are indicated.
Bausch & Lomb Corp executive Frederick Munsch, SVP, Controller and CAO, reported a sale of 52,900 Common Shares on August 10, 2026 in an open-market or private transaction at a weighted average price of $16.78 per share. The shares were sold in multiple trades between $16.73 and $16.85 per share, leaving him with 45,831 Common Shares held directly after the transaction.